Last reviewed · How we verify
Advanced renal cell carcinoma (RCC) after failure of prior therapy
Approved treatments
- Axitinib (AG-013736) · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Advanced renal cell carcinoma (RCC) after failure of prior therapy patent landscape — cliff calendar, originator estates, attackable patents
- Advanced renal cell carcinoma (RCC) after failure of prior therapy treatment landscape brief
- Advanced renal cell carcinoma (RCC) after failure of prior therapy treatment updates RSS
Frequently asked questions about Advanced renal cell carcinoma (RCC) after failure of prior therapy
What drugs treat Advanced renal cell carcinoma (RCC) after failure of prior therapy?
Tracked treatments include Axitinib (AG-013736).
What is the treatment for Advanced renal cell carcinoma (RCC) after failure of prior therapy?
Standard treatment for Advanced renal cell carcinoma (RCC) after failure of prior therapy includes Axitinib (AG-013736). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Advanced renal cell carcinoma (RCC) after failure of prior therapy patent cliff · Advanced renal cell carcinoma (RCC) after failure of prior therapy CI report
- Treatment: Axitinib (AG-013736) · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing